Astellas Pharma Inc. v. Aurobindo Pharma Ltd.

Application Number	Patent Number	External Links
-	US7342117	Espacenet Google Patents
-	US7982049	Espacenet Google Patents
-	US8835474	Espacenet Google Patents
-	USRE44872	Espacenet Google Patents

COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2012295.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/9/2016. Date of Expiration of Patent: 11/4/2023.Thirty Month Stay Deadline: 12/28/2019. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Astellas Pharma Inc. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd. filed by Astellas Ireland Co., Ltd. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Pharma Global Development, Inc. (nmg) (Entered: 10/13/2016)

2016-10-13

1

View

SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. Aurolife Pharma LLC served on 10/14/2016, answer due 11/4/2016. (Blumenfeld, Jack) (Entered: 10/17/2016)

2016-10-17

1

View

SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. Aurobindo Pharma USA, Inc. served on 10/14/2016, answer due 11/4/2016. (Blumenfeld, Jack) (Entered: 10/17/2016)

2016-10-17

1

View

STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma USA, Inc. and Aurolife Pharma LLC to respond to the Complaint to December 19, 2016 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Noreika, Maryellen) (Entered: 10/19/2016)

2016-10-19

1

View

REQUEST FOR WAIVER of Service sent to Aurobindo Pharma Ltd. on 10/19/2016 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. Waiver of Service due by 11/18/2016. (Noreika, Maryellen) Modified on 10/20/2016 (fms). (Entered: 10/20/2016)

2016-10-20

1

View

WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Aurobindo Pharma Ltd. waiver sent on 10/19/2016, answer due 12/19/2016. (Noreika, Maryellen) (Entered: 10/20/2016)

2016-10-20

1

View

MOTION for Pro Hac Vice Appearance of Attorney Robert L. Baechtold, John D. Murnane, Simon D. Roberts, and Christopher P. Borello - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Noreika, Maryellen) (Entered: 11/03/2016)

2016-11-03

1

View

ORDER, IT IS ORDERED that, on or before Wednesday, December 28, 2016, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/28/2016.) Signed by Judge Sue L. Robinson on 12/14/2016. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn) (Entered: 12/14/2016)

2016-12-14

1

View

MOTION for Pro Hac Vice Appearance of Attorney Gaby L. Longsworth, Attorney Daniel J. Ritterbeck and Attorney Dennies Varughese - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC. (Matterer, Mary) (Entered: 12/16/2016)

2016-12-16

1

View

ANSWER to 1 Complaint,, COUNTERCLAIM against Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Aurolife Pharma LLC.(Matterer, Mary) (Entered: 12/19/2016)

2016-12-19

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma USA, Inc. for Aurobindo Pharma Ltd.; Corporate Parent Aurolife Pharma LLC for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC. (Matterer, Mary) (Entered: 12/19/2016)

2016-12-19

1

View

Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding consolidated discovery and consolidated Markman proceedings - re (13 in 1:16-cv-00976-SLR, 13 in 1:16-cv-00976-SLR) Order,, Set Deadlines,. (Blumenfeld, Jack) (Entered: 12/28/2016)

2016-12-28

1

View

Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 2/22/2017 at 04:00 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 1/6/2017. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn) (Entered: 01/06/2017)

2017-01-06

1

View

STIPULATION TO EXTEND TIME for defendants to file an amended answer with supplemental counterclaims and for plaintiffs to move, answer, or otherwise respond to any supplemental counterclaims to January 17, 2017 and February 21, 2017, respectively - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Noreika, Maryellen) (Entered: 01/06/2017)

2017-01-06

1

View

MOTION for Pro Hac Vice Appearance of Attorney Jonathon E. Boljesic - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC. (Matterer, Mary) (Entered: 01/06/2017)

2017-01-06

1

View

Amended ANSWER to 16 Answer to Complaint,, Counterclaim, (Amended Answer, Defenses and Supplemental Counterclaims) by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC.(Matterer, Mary) (Entered: 01/17/2017)

2017-01-17

1

Download

MOTION for Pro Hac Vice Appearance of Attorney Erica L. Norey, Christopher J. Stankus, Anna E. Dwyer, and Chika S. Seidel - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Noreika, Maryellen) (Entered: 02/17/2017)

2017-02-17

1

View

SO ORDERED, re (19 in 1:16-cv-00954-SLR, 22 in 1:16-cv-00924-SLR, 22 in 1:16-cv-00908-SLR, 19 in 1:16-cv-00976-SLR, 23 in 1:16-cv-00942-SLR, 27 in 1:16-cv-00943-SLR, 22 in 1:16-cv-00905-SLR, 18 in 1:16-cv-00952-SLR, 20 in 1:16-cv-00930-SLR) MOTION for Pro Hac Vice Appearance of Attorney Erica L. Norey, Christopher J. Stankus, Anna E. Dwyer, and Chika S. Seidel filed by Astellas Pharma Global Development Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. Signed by Judge Sue L. Robinson on 2/17/2017. Associated Cases: 1:16-cv-00905-SLR et al.(fms)

2017-02-17

1

No Actions

PROPOSED ORDER -- Scheduling Order -- by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson enclosing order)(Blumenfeld, Jack) (Entered: 02/21/2017)

2017-02-21

1

View

ANSWER to 16 Answer to Complaint,, Counterclaim, 22 Supplemental Counterclaims by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Noreika, Maryellen) (Entered: 02/21/2017)

2017-02-21

1

View

Minute Entry for proceedings held before Judge Sue L. Robinson - Scheduling Conference held on 2/22/2017. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the court. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn)

2017-02-22

1

No Actions

PROPOSED ORDER -- Scheduling Order -- by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson enclosing order)(Blumenfeld, Jack) (Entered: 03/15/2017)

2017-03-15

1

View

SO ORDERED, re (22 in 1:16-cv-00954-SLR, 25 in 1:16-cv-00908-SLR, 25 in 1:16-cv-00905-SLR, 21 in 1:16-cv-00976-SLR, 24 in 1:16-cv-00924-SLR, 26 in 1:16-cv-00942-SLR, 22 in 1:16-cv-00930-SLR, 30 in 1:16-cv-00943-SLR, 21 in 1:16-cv-00952-SLR) SCHEDULING and CONSOLIDATION ORDER: ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 16-905-SLR. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery and all motions to dismiss, amend, transfer and any discovery motions permitted by the Magistrate Judge.( Joinder of Parties due by 2/2/2018., Amended Pleadings due by 6/8/2018., Fact Discovery completed by 7/13/2018., Expert Discovery due by 3/29/2019., A Status Conference is set for 7/11/2018 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson, Claim Construction Opening Brief due by 11/10/2017., Claim Construction Answering Brief due by 12/15/2017., Claim Construction Reply Brief due by 1/19/2018., Claim Construction Surreply Brief due by 2/16/2018., A Markman Hearing is set for 3/23/2018 at 09:00 AM in Courtroom 4B before Judge Sue L. Robinson., A Status Conference re: Expert Discovery is set for 3/13/2019 at 04:30 PM in Courtroom 4B before Judge Sue L. Robinson., A Final Pretrial Conference is set for 5/15/2019 at 03:00 PM in Courtroom 4B before Judge Sue L. Robinson., A Bench Trial is set for 6/3/2019 at 09:00 AM in Courtroom 4B before Judge Sue L. Robinson.). Signed by Judge Sue L. Robinson on 3/16/2017. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn)

2017-03-16

1

No Actions

Case associated with lead case: Create association to 1:16-cv-00905-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 16-905-SLR. (nmfn)

2017-03-16

1

No Actions

CASE REFERRED to Magistrate Judge Christopher J. Burke. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn)

2017-03-16

1

No Actions

Create Case Association - dkt in member case for Consol or MDL

2017-03-16

1

No Actions

Case Reassigned to Judge Joseph F. Bataillon of the District of Nebraska (in lieu of Vacant Judgeship). Please include the initials of the Judge (JFB) after the case number on all documents filed. Associated Cases: 1:16-cv-00905-JFB-CJB, 1:16-cv-00908-JFB-CJB, 1:16-cv-00924-JFB-CJB, 1:16-cv-00930-JFB-CJB, 1:16-cv-00942-JFB-CJB, 1:16-cv-00943-JFB-CJB, 1:16-cv-00952-JFB-CJB, 1:16-cv-00954-JFB-CJB and 1:16-cv-00976-JFB-CJB (rjb)

2017-08-01

1

No Actions

ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: This case shall be immediately referred to Magistrate Judge Christopher J. Burke. Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all dispositive and nondispositive matters on all issues, including claim construction, except for summary judgments, Daubert motions and pretrial motions in limine. On all dispositive matters, the magistrate judge shall issue a report and recommendation. The parties have the right to file objections to the report and recommendation, or in the case of nondispositive matters, file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 8/10/2017. Associated Cases: 1:16-cv-00905-JFB-CJB et al. (Brunswick, Amy) (Entered: 08/10/2017)

2017-08-10

1

View

Oral Order

2017-08-10

1

No Actions

STIPULATION of Dismissal Without Prejudice by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 03/15/2019)

2019-03-15

1

View

ORDER approving D.I. 28 Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Joseph F. Bataillon on 3/18/2019. (ceg) (Entered: 03/18/2019)

2019-03-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 05/15/2019)

2019-03-18

1

View

ORAL ORDER Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 11/25/2020. Associated Cases: 1:20-cv-01589-JFB et al.(AEV) (Entered: 11/25/2020)

2020-11-25

1

View

Oral Order

2020-11-25

1

No Actions

Overview

Parties

Counter Claimant

Aurolife Pharma LLC Follow

Represented By

Counter Defendant

Astellas Pharma Global Development, Inc. Follow

Represented By

Astellas Ireland Co., Ltd. Follow

Represented By

Defendant

Aurobindo Pharma Ltd. Follow

Represented By

Aurobindo Pharma USA, Inc. Follow

Represented By

Plaintiff

Astellas Pharma Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 10/13/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/9/2016. Date of Expiration of Patent: 11/4/2023.Thirty Month Stay Deadline: 12/28/2019. (nmg) (Entered: 10/13/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E. (nmg) (Entered: 10/13/2016)

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Astellas Pharma Inc. (nmg) (Entered: 10/13/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd. filed by Astellas Ireland Co., Ltd. (nmg) (Entered: 10/13/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Pharma Global Development, Inc. (nmg) (Entered: 10/13/2016)

SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. Aurolife Pharma LLC served on 10/14/2016, answer due 11/4/2016. (Blumenfeld, Jack) (Entered: 10/17/2016)

SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. Aurobindo Pharma USA, Inc. served on 10/14/2016, answer due 11/4/2016. (Blumenfeld, Jack) (Entered: 10/17/2016)

STIPULATION TO EXTEND TIME for Defendants Aurobindo Pharma USA, Inc. and Aurolife Pharma LLC to respond to the Complaint to December 19, 2016 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Noreika, Maryellen) (Entered: 10/19/2016)

REQUEST FOR WAIVER of Service sent to Aurobindo Pharma Ltd. on 10/19/2016 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. Waiver of Service due by 11/18/2016. (Noreika, Maryellen) Modified on 10/20/2016 (fms). (Entered: 10/20/2016)

WAIVER OF SERVICE returned executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.: For Aurobindo Pharma Ltd. waiver sent on 10/19/2016, answer due 12/19/2016. (Noreika, Maryellen) (Entered: 10/20/2016)

MOTION for Pro Hac Vice Appearance of Attorney Gaby L. Longsworth, Attorney Daniel J. Ritterbeck and Attorney Dennies Varughese - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC. (Matterer, Mary) (Entered: 12/16/2016)

ANSWER to 1 Complaint,, COUNTERCLAIM against Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. by Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd., Aurolife Pharma LLC.(Matterer, Mary) (Entered: 12/19/2016)

Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld regarding consolidated discovery and consolidated Markman proceedings - re (13 in 1:16-cv-00976-SLR, 13 in 1:16-cv-00976-SLR) Order,, Set Deadlines,. (Blumenfeld, Jack) (Entered: 12/28/2016)

Order Setting In-Person Patent Scheduling Conference: A Scheduling Conference is set for 2/22/2017 at 04:00 PM in Courtroom 4B before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 1/6/2017. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn) (Entered: 01/06/2017)

MOTION for Pro Hac Vice Appearance of Attorney Jonathon E. Boljesic - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC. (Matterer, Mary) (Entered: 01/06/2017)

Amended ANSWER to 16 Answer to Complaint,, Counterclaim, (Amended Answer, Defenses and Supplemental Counterclaims) by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC.(Matterer, Mary) (Entered: 01/17/2017)

PROPOSED ORDER -- Scheduling Order -- by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson enclosing order)(Blumenfeld, Jack) (Entered: 02/21/2017)

ANSWER to 16 Answer to Complaint,, Counterclaim, 22 Supplemental Counterclaims by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Noreika, Maryellen) (Entered: 02/21/2017)

Minute Entry for proceedings held before Judge Sue L. Robinson - Scheduling Conference held on 2/22/2017. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the court. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn)

PROPOSED ORDER -- Scheduling Order -- by Astellas Ireland Co., Ltd., Astellas Pharma Global Development Inc., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson enclosing order)(Blumenfeld, Jack) (Entered: 03/15/2017)

Case associated with lead case: Create association to 1:16-cv-00905-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 16-905-SLR. (nmfn)

CASE REFERRED to Magistrate Judge Christopher J. Burke. Associated Cases: 1:16-cv-00905-SLR et al.(nmfn)

Create Case Association - dkt in member case for Consol or MDL

Oral Order

STIPULATION of Dismissal Without Prejudice by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 03/15/2019)

ORDER approving D.I. 28 Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Joseph F. Bataillon on 3/18/2019. (ceg) (Entered: 03/18/2019)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,342,117 B2; 7,982,049 B2; 8,835,474 B2; RE44,872 E. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 05/15/2019)

Oral Order

Track Case Updates

Aurolife Pharma LLC

Astellas Pharma Global Development, Inc.

Astellas Ireland Co., Ltd.

Aurobindo Pharma Ltd.

Aurobindo Pharma USA, Inc.

Astellas Pharma Inc.